On CNBC’s “Halftime Report Final Trades,” on Monday, Jim Lebenthal, partner at Cerity Partners, said AbbVie Inc (NYSE:ABBV) has gained 30% this year. The stock has a good dividend yield and also has an attractive valuation, he added.
According to recent news, the Food and Drug Administration approved an updated indication statement for RINVOQ (upadacitinib) on Oct. 13 for the treatment of inflammatory bowel disease.
Stephen Weiss, chief investment officer and managing partner of Short Hills Capital Partners, said Amazon.com, Inc. (NASDAQ:AMZN) gained on Monday in the bounce back, but the stock has lagged the other AI plays.
Amazon.com is preparing to …
Full story available on Benzinga.com
On CNBC’s “Halftime Report Final Trades,” on Monday, Jim Lebenthal, partner at Cerity Partners, said AbbVie Inc (NYSE:ABBV) has gained 30% this year. The stock has a good dividend yield and also has an attractive valuation, he added.
According to recent news, the Food and Drug Administration approved an updated indication statement for RINVOQ (upadacitinib) on Oct. 13 for the treatment of inflammatory bowel disease.
Stephen Weiss, chief investment officer and managing partner of Short Hills Capital Partners, said Amazon.com, Inc. (NASDAQ:AMZN) gained on Monday in the bounce back, but the stock has lagged the other AI plays.
Amazon.com is preparing to …
Full story available on Benzinga.com
On CNBC’s “Halftime Report Final Trades,” on Monday, Jim Lebenthal, partner at Cerity Partners, said AbbVie Inc (NYSE:ABBV) has gained 30% this year. The stock has a good dividend yield and also has an attractive valuation, he added.
According to recent news, the Food and Drug Administration approved an updated indication statement for RINVOQ (upadacitinib) on Oct. 13 for the treatment of inflammatory bowel disease.
Stephen Weiss, chief investment officer and managing partner of Short Hills Capital Partners, said Amazon.com, Inc. (NASDAQ:AMZN) gained on Monday in the bounce back, but the stock has lagged the other AI plays.
Amazon.com is preparing to …Full story available on Benzinga.com Read MoreABBV, AMZN, DDOG, Halftime Report Final Trades, Jenny Van Leeuwen Harrington, Jim Lebenthal, Joseph M. Terranova, Long Ideas, News, Stephen Weiss, TSLX, Markets, Media, Trading Ideas, AMZN, US0231351067, ABBV, TSLX, DDOG, Long Ideas, News, Markets, Media, Trading Ideas, Benzinga Markets
